For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Patients not horsing around when change of antidepressant makes them feel worse
+News
Patients not horsing around when change of antidepressant makes them feel worse
Tuesday 23 June 2020, 04:22 PM

“My horse doesn’t like me any more,” one of GP William Ferguson’s patients told him after switching from a branded anti-depressant to a generic
Switching to generics works very well for just about every drug. But, with psychotropic drugs, the literature contains recurring themes of patients de
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Ferguson W, Clapshaw L. Study of mental health outcomes associated with different brands of venlafaxine at the Kumeu medical centre from January 2017 to October 2018. Ther Adv Psychopharmacol 2020;10:1–12. Online 26 May.
https://journals.sagepub.com/doi/pdf/10.1177/2045125320927309